ABT Abbott Laboratories Common Stock
关于 Abbott Laboratories Common Stock 公司概况(来自维基百科)
雅培,美國的跨國上市公司,總部位於伊利諾州芝加哥市中心北部的亞培園區。員工有72000多人,產品與服務覆蓋全球各國市場。
阅读更多
雅培(英語:Abbott Laboratories,臺灣稱為亞培),美國的跨國上市公司(NYSE:ABT),總部位於伊利諾州芝加哥市中心北部的亞培園區。員工有72000多人,產品與服務覆蓋全球各國市場。
歷史
雅培成立於1888年,創辦人為美國醫師華勒斯雅培。雅培以製藥、醫療器材與營養產品為主要事業,並在進行了幾次大型的事業併購。旗下產品分為動物健康、醫療診斷、營養產品、心血管相關,當中包括動物麻醉用品和血管相關醫療器材。
香港雅培寫字樓在炮台山電氣道友邦廣場,並在1959年成立。1983年,美國雅培公司在台湾台北市成立美商亞培藥廠公司台灣分公司,並成立台中辦事處、高雄辦事處。
2009年3月30日以总额约28亿美元的价格,完成了对眼力健公司(Advanced Medical Optics, Inc.)的要约收购。至此,眼力健成为雅培旗下的全资子公司,并更名为雅培医疗光学公司。
2009年9月28日將以45億歐元(約合66億美元)現金收購比利時化學品及製藥商蘇威集團(Solvay Group)的製藥部門Solvay Pharmaceuticals。還有3億歐元將在二零一一年至二零一三年期間支付。蘇威在聲明中表示,收購條件中還包括4億歐元的退休金。Solvay Pharmaceuticals在全球擁有9000名員工,2008年營收達到27億歐元。
2011年10月19日計劃分拆為品牌藥業務和多元化醫療用品兩家獨立的公開上市公司。
2012年雅培總公司將公司業務分拆上市,奶粉業務將繼續保留雅培的名字,另一部分稱艾伯维,專營生產醫療設備及研發藥品,在2013年一月初正式分拆。
2014年投资2.3亿美元在浙江嘉兴建立的一座营养品工厂正式开工。这是雅培目前在中国大陸最大的投资项目。雅培中国大陸总部位于上海,在华拥有4000多名员工。
2015年7月22日美國醫療設備製造商聖猶達醫療公司(St. Jude Medical),同意以大約34億美元現金收購心臟相關醫療設備製造商Thoratec(THOR)。
2016年4月28日雅培製藥同意以每股46.75美元現金加0.8708股票換取1股St. Jude股份的方式斥資250億美元收購心臟醫療設備製造商聖猶達醫療St. Jude Medical Inc.(STJ)。
2017年4月15日斥資53億美元收購診斷測試用品商Alere。 根據建議,每股收購價為51美元。
2022年2月,有4名美國嬰兒可能因使用雅培旗下品牌奶粉導致感染克羅諾桿菌及沙門氏菌。雅培宣佈召回在美国密歇根州工厂生产的三个品牌的婴儿配方产品。美國食品及藥物監管局宣佈開啟調查,中國海關總署呼籲中國消費者不要購買雅培旗下部分嬰幼兒產品。
参考来源
外部連結
雅培(中国) (页面存档备份,存于互联网档案馆)
雅培(美國) (页面存档备份,存于互联网档案馆)
Abbott的Facebook專頁
Abbott的Instagram帳戶
YouTube上的Abbott頻道
雅培(香港) (页面存档备份,存于互联网档案馆)
亞培(台灣) (页面存档备份,存于互联网档案馆)
来源:维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
ABT 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
ABT 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年7月15日 | $0.6300 |
| 2026年4月15日 | $0.6300 |
| 2026年1月15日 | $0.6300 |
| 2025年10月15日 | $0.5900 |
| 2025年7月15日 | $0.5900 |
| 2025年4月15日 | $0.5900 |
| 2025年1月15日 | $0.5900 |
| 2024年10月15日 | $0.5500 |
| 2024年7月15日 | $0.5500 |
| 2024年4月12日 | $0.5500 |
| 2024年1月11日 | $0.5500 |
| 2023年10月12日 | $0.5100 |
| 2023年7月13日 | $0.5100 |
| 2023年4月13日 | $0.5100 |
| 2023年1月12日 | $0.5100 |
| 2022年10月13日 | $0.4700 |
| 2022年7月14日 | $0.4700 |
| 2022年4月13日 | $0.4700 |
| 2022年1月13日 | $0.4700 |
| 2021年10月14日 | $0.4500 |
ABT 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 11 33.3%
- 买入 13 39.4%
- 持有 9 27.3%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
24 位分析师 · 2026-08-13收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $1.31 | $1.29 | 0.02% |
| 2026年3月31日 | $1.15 | $1.16 | -0.01% |
| 2025年12月31日 | $1.50 | $1.51 | -0.01% |
| 2025年9月30日 | $1.30 | $1.31 | -0.01% |
| 2025年6月30日 | $1.26 | $1.27 | -0.01% |
| 2025年3月31日 | $1.09 | $1.08 | 0.01% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Cost of Revenue | $19.32B | $18.71B | $17.98B | $19.14B | $18.54B | $15.00B | $13.23B | $12.71B | $12.41B | $9.09B | $8.75B | $9.22B | |
| R&D Expense | $2.94B | $2.84B | $2.74B | $2.89B | $2.74B | $2.42B | $2.44B | $2.30B | $2.26B | · | · | · | |
| SG&A Expense | $12.33B | $11.70B | $10.95B | $11.25B | $11.32B | $9.70B | $9.77B | $9.74B | $9.18B | $6.74B | $6.79B | $6.53B | |
| Operating Expenses | $36.27B | $35.12B | $33.63B | $35.29B | $34.65B | $29.25B | $27.37B | $26.93B | $25.83B | $17.83B | $17.54B | $17.65B | |
| Operating Income | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.56B | $3.03B | $2.87B | $2.60B | |
| Interest Expense | · | · | $637M | $558M | $533M | $546M | $670M | $826M | $904M | $431M | $163M | $150M | |
| Interest Income | $308M | $344M | $385M | $183M | $43M | $46M | $94M | $105M | $124M | $99M | $105M | $77M | |
| Other Non-op | $548M | $376M | $479M | $321M | $277M | $103M | $191M | $139M | $1.41B | $-786M | $281M | $-14M | |
| Pretax Income | $8.47B | $7.01B | $6.66B | $8.31B | $8.21B | $4.97B | $4.08B | $2.87B | $2.23B | $1.41B | $3.18B | $2.52B | |
| Income Tax | $1.94B | $-6.39B | $941M | $1.37B | $1.14B | $497M | $390M | $539M | $1.88B | $350M | $577M | $797M | |
| Net Income | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| EPS (Basic) | $3.73 | $7.67 | $3.28 | $3.94 | $3.97 | $2.52 | $2.07 | $1.34 | $0.27 | $0.94 | $2.94 | $1.50 | |
| EPS (Diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | |
| Shares (Basic) | 1,741,000,000 | 1,740,000,000 | 1,740,000,000 | 1,753,000,000 | 1,775,000,000 | 1,773,000,000 | 1,768,000,000 | 1,758,000,000 | 1,740,000,000 | 1,477,000,000 | 1,496,000,000 | 1,516,000,000 | |
| Shares (Diluted) | 1,748,000,000 | 1,748,000,000 | 1,749,000,000 | 1,764,000,000 | 1,789,000,000 | 1,786,000,000 | 1,781,000,000 | 1,770,000,000 | 1,749,000,000 | 1,483,000,000 | 1,506,000,000 | 1,527,000,000 | |
| EBITDA | $8.05B | $6.83B | $6.48B | $8.36B | $8.43B | $5.36B | $4.53B | $3.65B | $1.73B | $3.19B | $2.87B | $2.60B |
资产负债表 27
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.52B | $7.62B | $6.90B | $9.88B | $9.80B | $6.84B | $3.86B | $3.84B | $9.41B | $18.62B | $5.00B | $4.06B | |
| Short-term Investments | $417M | $351M | $383M | $288M | $450M | $310M | $280M | $242M | $203M | $155M | $1.12B | $397M | |
| Receivables | $7.93B | $6.92B | $6.57B | $6.22B | $6.49B | $6.41B | $5.42B | $5.18B | $5.25B | $3.25B | $3.42B | $3.59B | |
| Inventory | $6.49B | $6.19B | $6.57B | $6.17B | $5.16B | $5.01B | $4.32B | $3.80B | $3.60B | $2.43B | $2.60B | $2.64B | |
| Other Current Assets | · | · | · | · | · | · | · | · | $1.67B | $1.81B | $1.91B | $1.98B | |
| Current Assets | $26.00B | $23.66B | $22.67B | $25.22B | $24.24B | $20.44B | $15.67B | $14.63B | $20.15B | $26.78B | $14.15B | $13.56B | |
| PP&E (Net) | $11.82B | $10.66B | $10.15B | $9.16B | $8.96B | $9.03B | $8.04B | $7.56B | $7.61B | $5.71B | $5.73B | $5.93B | |
| PP&E (Gross) | $25.22B | $22.74B | $21.93B | $20.21B | $19.36B | $18.79B | $16.80B | $15.71B | $15.27B | $12.37B | $12.38B | $12.63B | |
| Accum. Depreciation | $13.41B | $12.08B | $11.78B | $11.05B | $10.40B | $9.76B | $8.76B | $8.14B | $7.66B | $6.66B | $6.65B | $6.70B | |
| Goodwill | $24.04B | $23.11B | $23.68B | $22.80B | $23.23B | $23.74B | $23.20B | $23.25B | $24.02B | $7.68B | $9.64B | $10.07B | |
| Intangibles | $5.53B | $6.65B | $8.81B | $10.45B | $12.74B | $14.78B | $17.02B | $18.94B | $21.47B | $4.54B | $5.56B | $6.20B | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $2.12B | $3.29B | |
| Total Assets | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Short-term Debt | · | · | · | · | $0 | $213M | $201M | $200M | $206M | $1.32B | $3.13B | $4.38B | |
| Current Liabilities | $16.50B | $14.16B | $13.84B | $15.49B | $13.11B | $11.91B | $10.86B | $9.01B | $8.91B | $6.66B | $9.19B | $10.47B | |
| Capital Leases | $931M | $896M | $949M | $943M | $956M | $902M | $755M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $860M | |
| Other Non-current Liabilities | $2.54B | $2.59B | $3.47B | $3.80B | $3.69B | · | · | · | $9.03B | $4.55B | $4.86B | $5.60B | |
| Long-term Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.53B | $17.94B | $19.37B | $27.72B | $20.68B | $5.87B | $3.45B | |
| Total Debt | $12.93B | $14.12B | $14.68B | $16.77B | $18.05B | $18.75B | $18.14B | $19.57B | $27.92B | $22.01B | $9.00B | $7.84B | |
| Common Stock | $25.53B | $25.15B | $24.87B | $24.71B | $24.47B | $24.14B | $23.85B | $23.51B | $23.21B | $13.03B | $12.73B | $12.38B | |
| Retained Earnings | $49.78B | $47.26B | $37.55B | $35.26B | $31.53B | $27.63B | $25.85B | $24.56B | $23.98B | $25.57B | $25.76B | $22.87B | |
| Treasury Stock | $17.18B | $16.84B | $15.98B | $15.23B | $11.82B | $10.04B | $10.15B | $9.96B | $10.22B | $10.79B | $10.62B | $8.68B | |
| AOCI | $-6.00B | $-7.91B | $-7.84B | $-8.05B | $-8.37B | $-8.95B | $-8.46B | $-7.59B | $-6.06B | $-7.26B | $-6.66B | $-5.05B | |
| Stockholders' Equity | $52.13B | $47.66B | $38.60B | $36.69B | $35.80B | $32.78B | $31.09B | $30.52B | $30.90B | $20.54B | $21.21B | $21.53B | |
| Liabilities + Equity | $86.71B | $81.41B | $73.21B | $74.44B | $75.20B | $72.55B | $67.89B | $67.17B | $76.25B | $52.67B | $41.25B | $41.21B | |
| Shares Outstanding | 1,996,795,525 | 1,991,472,630 | 1,987,883,852 | 1,986,519,278 | 1,985,273,421 | 1,981,156,896 | 1,976,855,085 | 1,971,189,465 | 1,965,908,188 | 1,707,475,455 | 1,702,017,390 | 1,694,929,949 |
现金流 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $664M | $673M | $644M | $685M | $640M | $546M | $519M | $477M | $406M | $310M | $292M | $246M | |
| Deferred Tax | $441M | $-7.96B | $-461M | $-659M | $-509M | $-108M | $-491M | $745M | $-890M | $-127M | $293M | $302M | |
| Amort. of Intangibles | $1.68B | $1.88B | $1.97B | $2.01B | $2.05B | $2.13B | $1.94B | $2.18B | $1.98B | $550M | $601M | $630M | |
| Restructuring | · | · | · | · | · | $36M | $66M | $28M | · | · | · | · | |
| Operating Cash Flow | $9.57B | $8.56B | $7.26B | $9.58B | $10.53B | $7.90B | $6.14B | $6.30B | $5.57B | $3.20B | $2.97B | $3.67B | |
| CapEx | $2.17B | $2.21B | $2.20B | $1.78B | $1.89B | $2.18B | $1.64B | $1.39B | $1.14B | $1.12B | $1.11B | $1.08B | |
| Investing Cash Flow | $-2.42B | $-2.34B | $-3.13B | $-1.74B | $-2.01B | $-2.21B | $-1.81B | $-1.36B | $-9.62B | $-248M | $406M | $-202M | |
| Debt Issued | · | · | · | · | $4M | $1.28B | $1.84B | $4.01B | $6.74B | $14.93B | $2.48B | · | |
| Net Debt Issued | · | · | · | · | $-44M | $-52M | $-1.60B | $-8.42B | $-1.91B | $14.92B | $2.43B | $-577M | |
| Stock Repurchased | $893M | $1.29B | $1.23B | $3.79B | $2.30B | $403M | $718M | $238M | $117M | $522M | $2.24B | $2.19B | |
| Net Stock Activity | $-893M | $-1.29B | $-1.23B | $-3.79B | $-2.30B | $-403M | $-718M | $-238M | $-117M | $-522M | $-2.24B | $-2.19B | |
| Dividends Paid | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B | |
| Financing Cash Flow | $-6.31B | $-5.40B | $-7.09B | $-7.64B | $-5.49B | $-2.78B | $-4.29B | $-10.39B | $-5.28B | $11.15B | $-2.24B | $-2.74B | |
| Net Change in Cash | $906M | $720M | $-2.99B | $83M | $2.96B | $2.98B | $16M | $-5.56B | $-9.21B | $13.62B | $938M | $588M | |
| Taxes Paid | $1.93B | $1.72B | $1.48B | $1.86B | $1.94B | $970M | $930M | $740M | $570M | $620M | $631M | · | |
| Free Cash Flow | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B | $5.72B | $4.50B | $4.91B | $4.43B | $2.08B | $1.86B | $2.60B | |
| Levered FCF | · | · | $4.51B | $7.34B | $8.19B | $5.23B | $3.89B | $4.23B | $4.29B | $1.76B | $1.72B | $2.50B |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| Net Margin | 14.7% | 31.9% | 14.3% | 15.9% | 16.4% | 13.0% | 11.6% | 7.7% | 1.7% | 6.7% | 21.7% | 11.3% | |
| Pretax Margin | 19.1% | 16.7% | 16.6% | 19.0% | 19.1% | 14.4% | 12.8% | 9.4% | 8.2% | 6.8% | 15.6% | 12.4% | |
| EBITDA Margin | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% | 15.5% | 14.2% | 11.9% | 6.3% | 15.3% | 14.1% | 12.8% | |
| ROA | 7.8% | 17.3% | 7.8% | 9.3% | 9.6% | 6.4% | 5.5% | 3.3% | 0.74% | 3.0% | 10.7% | 5.4% | |
| ROE | 13.1% | 31.1% | 15.2% | 19.1% | 20.6% | 14.1% | 12.0% | 7.7% | 1.8% | 6.7% | 20.7% | 9.8% | |
| ROIC | 9.5% | 21.1% | 10.4% | 13.1% | 13.5% | 9.4% | 8.3% | 5.9% | 0.46% | 5.6% | 7.8% | 6.0% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 | 1.7 | 1.4 | 1.6 | 2.3 | 4.0 | 1.5 | 1.4 | |
| Quick Ratio | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 0.9 | 1.0 | 1.7 | 3.3 | 1.0 | 0.8 | |
| Debt / Equity | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.9 | 1.1 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.2 | 0.3 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.6 | 0.9 | 1.0 | 0.3 | 0.2 | |
| Interest Coverage | · | · | 10.2 | 15.0 | 15.8 | 9.8 | 6.8 | 4.4 | 1.9 | 7.4 | 17.6 | 17.3 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | |
| Inventory Turnover | 3.0 | 2.9 | 2.8 | 3.4 | 3.6 | 3.2 | 3.3 | 3.4 | 4.1 | 3.6 | 3.3 | 3.5 | |
| Receivables Turnover | 6.0 | 6.2 | 6.3 | 6.9 | 6.7 | 5.8 | 6.0 | 5.9 | 6.4 | 6.3 | 5.8 | 5.3 |
增长率 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.7% | 4.6% | -8.1% | 1.3% | 24.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.51% | -0.88% | 5.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -51.3% | 134.4% | -16.6% | -0.76% | 57.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.7% | 24.7% | 9.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 8.3% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -51.3% | 134.2% | -17.4% | -1.9% | 57.3% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -2.0% | 23.8% | 8.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 7.7% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 10.0% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 17
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B | $34.61B | $31.90B | $30.58B | $27.39B | $20.85B | $20.41B | $20.25B | |
| Net Income TTM | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B | $4.50B | $3.69B | $2.37B | $477M | $1.40B | $4.42B | $2.28B | |
| Market Cap | $250.18B | $225.26B | $218.81B | $218.10B | $279.41B | $216.92B | $171.71B | $142.58B | $112.19B | $65.58B | · | · | |
| Enterprise Value | $254.17B | $231.41B | $226.21B | $224.70B | $287.21B | $228.52B | $185.71B | $158.06B | $130.51B | $68.82B | · | · | |
| P/E | 33.7 | 14.8 | 33.8 | 28.1 | 35.7 | 43.8 | 42.2 | 54.4 | 211.4 | 40.9 | 15.4 | 30.2 | |
| P/S | 5.6 | 5.4 | 5.5 | 5.0 | 6.5 | 6.3 | 5.4 | 4.7 | 4.1 | 3.1 | · | · | |
| P/B | 4.8 | 4.7 | 5.7 | 5.9 | 7.8 | 6.6 | 5.5 | 4.7 | 3.6 | 3.2 | · | · | |
| P / Tangible Book | 11.1 | 12.6 | 35.8 | 63.5 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 26.2 | 26.3 | 30.1 | 22.8 | 26.5 | 27.5 | 28.0 | 22.6 | 20.1 | 20.5 | · | · | |
| P / FCF | 33.8 | 35.5 | 43.3 | 27.9 | 32.3 | 37.9 | 38.2 | 29.1 | 25.3 | 31.5 | · | · | |
| EV / EBITDA | 31.6 | 33.9 | 34.9 | 26.9 | 34.1 | 42.7 | 41.0 | 43.3 | 75.6 | 21.6 | · | · | |
| EV / FCF | 34.4 | 36.4 | 44.7 | 28.8 | 33.2 | 39.9 | 41.3 | 32.2 | 29.4 | 33.1 | · | · | |
| EV / Revenue | 5.7 | 5.5 | 5.6 | 5.1 | 6.7 | 6.6 | 5.8 | 5.2 | 4.8 | 3.3 | · | · | |
| Dividend Yield | 1.7% | 1.7% | 1.6% | 1.5% | 1.1% | 1.2% | 1.3% | 1.4% | 1.7% | 2.4% | · | · | |
| Earnings Yield | 3.0% | 6.8% | 3.0% | 3.6% | 2.8% | 2.3% | 2.4% | 1.8% | 0.47% | 2.5% | 6.5% | 3.3% | |
| Payout Ratio | 63.1% | 28.6% | 62.1% | 47.7% | 45.3% | 57.0% | 61.6% | 83.4% | 387.6% | 109.9% | 32.6% | 58.8% | |
| Annual Payout | $4.12B | $3.84B | $3.56B | $3.31B | $3.20B | $2.56B | $2.27B | $1.97B | $1.85B | $1.54B | $1.44B | $1.34B |
损益表 17
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.59B | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B | $10.97B | $10.63B | $10.38B | $9.96B | $10.24B | $10.14B | $9.98B | $9.75B | $10.09B | $10.41B | |
| Cost of Revenue | $5.33B | $4.89B | $4.92B | $5.08B | $4.85B | $4.47B | $4.94B | $4.70B | $4.60B | $4.46B | $4.56B | $4.61B | $4.48B | $4.33B | $4.59B | $4.63B | |
| R&D Expense | $892M | $767M | $735M | $766M | $725M | $716M | $749M | $713M | $698M | $684M | $700M | $672M | $715M | $654M | $725M | $782M | |
| SG&A Expense | $4.03B | $3.74B | $3.13B | $3.05B | $3.09B | $3.06B | $2.91B | $2.90B | $2.94B | $2.96B | $2.72B | $2.72B | $2.74B | $2.76B | $2.97B | $2.73B | |
| Operating Expenses | $10.90B | $9.82B | $9.21B | $9.31B | $9.09B | $8.66B | $9.06B | $8.78B | $8.71B | $8.58B | $8.46B | $8.50B | $8.44B | $8.24B | $8.79B | $8.64B | |
| Operating Income | $1.69B | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B | $1.91B | $1.86B | $1.67B | $1.39B | $1.78B | $1.65B | $1.54B | $1.51B | $1.30B | $1.77B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141M | · | $166M | $159M | $153M | · | $141M | |
| Interest Income | $52M | $106M | $78M | $77M | $71M | $82M | $91M | $91M | $82M | $80M | $89M | $97M | $98M | $101M | $88M | $55M | |
| Other Non-op | $134M | $159M | $134M | $150M | $137M | $127M | $154M | $121M | $-10M | $111M | $109M | $83M | $176M | $111M | $68M | $93M | |
| Pretax Income | $1.52B | $1.45B | $2.36B | $2.18B | $2.15B | $1.78B | $2.03B | $1.94B | $1.61B | $1.44B | $1.79B | $1.67B | $1.64B | $1.56B | $1.32B | $1.76B | |
| Income Tax | $596M | $372M | $582M | $536M | $371M | $453M | $-7.20B | $294M | $305M | $211M | $201M | $235M | $261M | $244M | $287M | $323M | |
| Net Income | $928M | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B | $9.23B | $1.65B | $1.30B | $1.23B | $1.59B | $1.44B | $1.38B | $1.32B | $1.03B | $1.44B | |
| EPS (Basic) | $0.53 | $0.62 | $1.01 | $0.94 | $1.02 | $0.76 | $5.29 | $0.94 | $0.74 | $0.70 | $0.92 | $0.82 | $0.79 | $0.75 | $0.59 | $0.82 | |
| EPS (Diluted) | $0.53 | $0.61 | $1.01 | $0.94 | $1.01 | $0.76 | $5.26 | $0.94 | $0.74 | $0.70 | $0.91 | $0.82 | $0.78 | $0.75 | $0.59 | $0.81 | |
| Shares (Basic) | 1,740,420,000 | 1,742,480,000 | -3,483,785,000 | 1,742,142,000 | 1,743,437,000 | 1,739,206,000 | -3,482,709,000 | 1,739,466,000 | 1,743,040,000 | 1,740,203,000 | -3,480,797,000 | 1,738,700,000 | 1,740,359,000 | 1,741,738,000 | -3,515,744,000 | 1,752,968,000 | |
| Shares (Diluted) | 1,742,981,000 | 1,747,073,000 | -3,499,416,000 | 1,749,361,000 | 1,750,835,000 | 1,747,220,000 | -3,500,402,000 | 1,747,597,000 | 1,751,153,000 | 1,749,652,000 | -3,501,252,000 | 1,748,289,000 | 1,750,248,000 | 1,751,715,000 | -3,539,658,000 | 1,763,653,000 | |
| EBITDA | $1.69B | $1.34B | · | $2.06B | $2.05B | $1.69B | · | $1.86B | $1.67B | $1.39B | · | $1.65B | $1.54B | $1.51B | · | $1.77B |
资产负债表 23
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.10B | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B | $6.28B | · | $6.71B | $7.83B | $9.16B | · | $9.59B | |
| Short-term Investments | $499M | $492M | $417M | $222M | $331M | $312M | $351M | $230M | $232M | $367M | · | $338M | $320M | $371M | · | $313M | |
| Receivables | $8.60B | $8.21B | $7.93B | $8.14B | $7.97B | $7.33B | $6.92B | $7.05B | $6.85B | $6.61B | · | $6.50B | $6.17B | $6.02B | · | $6.41B | |
| Inventory | $7.32B | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B | $6.83B | · | $6.65B | $6.87B | $6.67B | · | $5.73B | |
| Current Assets | $24.52B | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B | $22.38B | · | $22.66B | $23.50B | $24.38B | · | $24.84B | |
| PP&E (Net) | $12.81B | $12.38B | $11.82B | $11.50B | $11.39B | $10.93B | $10.66B | $10.62B | $10.23B | $10.11B | · | $9.55B | $9.45B | $9.28B | · | $8.69B | |
| PP&E (Gross) | $26.47B | $25.74B | $25.22B | $24.82B | $24.47B | $23.42B | $22.74B | $22.86B | $22.06B | $22.05B | · | $21.11B | $20.93B | $20.61B | · | $19.31B | |
| Accum. Depreciation | $13.66B | $13.36B | $13.41B | $13.31B | $13.08B | $12.49B | $12.08B | $12.24B | $11.83B | $11.95B | · | $11.56B | $11.48B | $11.32B | · | $10.62B | |
| Goodwill | $35.24B | $35.22B | $24.04B | $23.97B | $23.95B | $23.36B | $23.11B | $23.66B | $23.31B | $23.38B | · | $23.28B | $23.26B | $22.93B | · | $22.28B | |
| Intangibles | $17.21B | $17.88B | $5.53B | $5.60B | $5.92B | $6.26B | $6.65B | $7.35B | $7.83B | $8.30B | · | $9.28B | $9.83B | $10.01B | · | $10.85B | |
| Total Assets | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Current Liabilities | $17.81B | $18.38B | $16.50B | $14.58B | $13.44B | $13.00B | $14.16B | $14.90B | $13.76B | $14.02B | · | $13.04B | $14.35B | $14.53B | · | $13.37B | |
| Capital Leases | · | · | $931M | · | · | · | $896M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $2.54B | · | · | · | $2.59B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $32.61B | $34.05B | $12.93B | $12.94B | $13.44B | $13.24B | $14.12B | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Total Debt | $32.61B | $34.05B | · | $12.94B | $13.44B | $13.24B | · | $14.98B | $14.75B | $14.59B | · | $15.53B | $16.85B | $16.90B | · | $16.41B | |
| Common Stock | $25.50B | $25.35B | $25.53B | $25.41B | $25.28B | $25.12B | $25.15B | $25.02B | $24.86B | $24.73B | · | $24.73B | $24.61B | $24.49B | · | $24.56B | |
| Retained Earnings | $49.79B | $49.96B | $49.78B | $49.10B | $48.47B | $47.72B | $47.26B | $39.06B | $38.35B | $38.01B | · | $36.92B | $36.35B | $35.87B | · | $35.12B | |
| Treasury Stock | $17.97B | $16.93B | $17.18B | $16.88B | $16.61B | $16.61B | $16.84B | $16.48B | $15.76B | $15.76B | · | $15.69B | $15.72B | $15.31B | · | $14.55B | |
| AOCI | $-6.21B | $-6.31B | $-6.00B | $-6.68B | $-6.58B | $-7.42B | $-7.91B | $-7.80B | $-8.13B | $-8.17B | $-7.84B | $-8.48B | $-8.07B | $-8.04B | $-8.05B | $-9.45B | |
| Stockholders' Equity | $51.11B | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B | $38.81B | · | $37.48B | $37.17B | $37.01B | · | $35.67B | |
| Liabilities + Equity | $109.22B | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B | $72.47B | · | $72.09B | $73.35B | $73.79B | · | $72.80B | |
| Shares Outstanding | 1,998,291,279 | 1,998,233,756 | 1,996,795,525 | 1,996,743,794 | 1,996,448,469 | 1,995,858,606 | 1,991,472,630 | 1,991,051,414 | 1,990,029,292 | 1,989,789,999 | 1,987,883,852 | 1,987,305,154 | 1,987,181,491 | 1,986,904,170 | 1,986,519,278 | 1,985,919,440 |
现金流 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $168M | $317M | $113M | $120M | $142M | $289M | $111M | $117M | $141M | $304M | $114M | $117M | $132M | $281M | $115M | $123M | |
| Amort. of Intangibles | $658M | $422M | $422M | $420M | $420M | $420M | $465M | $470M | $471M | $472M | $481M | $496M | $498M | $491M | $496M | $498M | |
| Operating Cash Flow | $2.49B | $1.31B | $3.31B | $2.79B | $2.05B | $1.42B | $2.87B | $2.71B | $1.96B | $1.02B | $3.04B | $1.88B | $1.20B | $1.14B | $2.33B | $2.78B | |
| CapEx | $497M | $399M | $689M | $496M | $502M | $484M | $720M | $556M | $533M | $398M | $755M | $560M | $507M | $380M | $610M | $467M | |
| Investing Cash Flow | $-673M | $-20.32B | $-913M | $-457M | $-582M | $-470M | $-866M | $-594M | $-453M | $-425M | $-824M | $-634M | $-1.21B | $-462M | $-632M | $-484M | |
| Debt Issued | $-33M | $19.86B | · | $0 | $2M | $1M | · | $1M | $221M | $0 | · | $0 | · | · | · | $1M | |
| Net Debt Issued | · | $18.44B | · | · | · | $-1.00B | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Repurchased | $1.04B | $180M | $302M | $305M | $6M | $280M | $315M | $751M | $3M | $226M | $259M | $2M | $426M | $540M | $685M | $798M | |
| Net Stock Activity | · | $-180M | · | · | · | $-280M | · | · | · | $-226M | · | · | · | $-540M | · | · | |
| Dividends Paid | $1.10B | $1.10B | $1.03B | $1.03B | $1.03B | $1.03B | $958M | $960M | $961M | $957M | $888M | $888M | $890M | $890M | $823M | $826M | |
| Financing Cash Flow | $-3.52B | $17.31B | $-1.40B | $-1.76B | $-1.10B | $-2.06B | $-1.86B | $-1.58B | $-791M | $-1.18B | $-2.05B | $-2.34B | $-1.29B | $-1.41B | $-1.46B | $-1.54B | |
| Net Change in Cash | $-1.70B | $-1.72B | $1.01B | $560M | $419M | $-1.08B | $58M | $571M | $703M | $-612M | $187M | $-1.13B | $-1.33B | $-721M | $288M | $657M | |
| Free Cash Flow | · | $916M | · | · | · | $933M | · | · | · | $627M | · | · | · | $763M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $507M | · | · | · | $634M | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| Net Margin | 7.4% | 9.7% | · | 14.5% | 16.0% | 12.8% | · | 15.5% | 12.6% | 12.3% | · | 14.2% | 13.8% | 13.5% | · | 13.8% | |
| Pretax Margin | 12.1% | 13.0% | · | 19.2% | 19.3% | 17.2% | · | 18.2% | 15.5% | 14.4% | · | 16.5% | 16.4% | 16.0% | · | 16.9% | |
| EBITDA Margin | 13.4% | 12.0% | · | 18.1% | 18.4% | 16.3% | · | 17.5% | 16.1% | 13.9% | · | 16.2% | 15.4% | 15.5% | · | 17.0% | |
| ROA | 0.96% | 1.1% | · | 2.1% | 2.3% | 1.7% | · | 2.2% | 1.8% | 1.7% | · | 2.0% | 1.9% | 1.8% | · | 2.0% | |
| ROE | 1.8% | 2.1% | · | 3.6% | 4.0% | 3.0% | · | 4.3% | 3.4% | 3.2% | · | 3.9% | 3.7% | 3.6% | · | 4.1% | |
| ROIC | 1.2% | 1.2% | · | 2.4% | 2.6% | 2.0% | · | 2.9% | 2.5% | 2.2% | · | 2.7% | 2.4% | 2.4% | · | 2.8% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.7 | 1.8 | 1.8 | · | 1.6 | 1.7 | 1.6 | · | 1.7 | 1.6 | 1.7 | · | 1.9 | |
| Quick Ratio | 0.8 | 0.8 | · | 1.1 | 1.1 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 1.0 | 1.1 | · | 1.2 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.2 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 9.8 | · | 9.9 | 9.7 | 9.9 | · | 12.6 |
效率 3
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.8 | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 | 1.5 | 1.5 | · | 1.6 |
估值 (TTM) 15
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $46.27B | $44.03B | · | $43.50B | $42.51B | $41.33B | · | $41.12B | $40.46B | $39.83B | · | $40.28B | $41.39B | $43.31B | · | $44.49B | |
| Net Income TTM | $5.43B | $5.83B | · | $6.39B | $6.05B | $5.50B | · | $5.61B | $5.34B | $5.35B | · | $5.56B | $6.15B | $7.22B | · | $8.00B | |
| Market Cap | $181.32B | $205.16B | · | $267.44B | $271.54B | $264.75B | · | $227.00B | $206.78B | $226.16B | · | $192.47B | $216.64B | $201.19B | · | $192.16B | |
| Enterprise Value | $208.33B | $231.91B | · | $272.65B | $277.69B | $271.15B | · | $234.19B | $214.32B | $234.09B | · | $200.95B | $225.33B | $208.56B | · | $198.66B | |
| P/E | 29.4 | 30.9 | · | 36.7 | 39.4 | 42.2 | · | 35.6 | 34.2 | 37.3 | · | 30.6 | 31.3 | 24.9 | · | 21.6 | |
| P/S | 3.9 | 4.7 | · | 6.1 | 6.4 | 6.4 | · | 5.5 | 5.1 | 5.7 | · | 4.8 | 5.2 | 4.6 | · | 4.3 | |
| P/B | 3.5 | 3.9 | · | 5.2 | 5.4 | 5.4 | · | 5.7 | 5.3 | 5.8 | · | 5.1 | 5.8 | 5.4 | · | 5.4 | |
| P / Tangible Book | · | · | · | 12.5 | 13.1 | 13.8 | · | 25.8 | 25.3 | 31.7 | · | 39.1 | 53.1 | 49.3 | · | 75.6 | |
| P / Cash Flow | · | 156.0 | · | · | · | 186.8 | · | · | · | 220.6 | · | · | · | 176.0 | · | · | |
| P / FCF | · | 224.0 | · | · | · | 283.8 | · | · | · | 360.7 | · | · | · | 263.7 | · | · | |
| EV / EBITDA | 123.1 | 172.4 | · | 132.5 | 135.3 | 160.2 | · | 126.0 | 128.4 | 168.9 | · | 122.0 | 146.1 | 138.2 | · | 112.2 | |
| EV / FCF | · | 253.2 | · | · | · | 290.6 | · | · | · | 373.4 | · | · | · | 273.3 | · | · | |
| EV / Revenue | 4.5 | 5.3 | · | 6.3 | 6.5 | 6.6 | · | 5.7 | 5.3 | 5.9 | · | 5.0 | 5.4 | 4.8 | · | 4.5 | |
| Earnings Yield | 3.4% | 3.2% | · | 2.7% | 2.5% | 2.4% | · | 2.8% | 2.9% | 2.7% | · | 3.3% | 3.2% | 4.0% | · | 4.6% | |
| Payout Ratio | · | 102.0% | · | · | · | 77.4% | · | · | · | 78.1% | · | · | · | 67.5% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $44.33B | $41.95B | $40.11B | $43.65B | $43.08B |
| 营业利润率 % | 18.2% | 16.3% | 16.2% | 19.2% | 19.6% |
| 净收入 | $6.52B | $13.40B | $5.72B | $6.93B | $7.07B |
| 稀释后每股收益 (EPS) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.2 | 0.3 | 0.4 | 0.5 | 0.5 |
| 流动比率 | 1.6 | 1.7 | 1.6 | 1.6 | 1.8 |
| 速动比率 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $7.39B | $6.35B | $5.06B | $7.80B | $8.65B |
最新新闻 提及该公司的近期头条新闻
- Abbott raises 2026 profit forecast on strength in diagnostics, heart devices
- Why Abbott Stock Jumped Today
- Is Abbott (ABT) the Best Longevity Stock to Buy Now?
- This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
- 2 只可长期持有的股息股票
- 雅培股票跌至52周新低,但内部人士正在抢购这家蓝筹股股息支付公司的股票
- 五月寻求可靠的股息收入?这两只股票值得关注
- 這個股息之王的回報在十年來從未如此之高。它買嗎?
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 3320 家申报者 · $77.5B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 174 (-46 与上一季度对比) | 261 (-30 与上一季度对比) | 1059 (-69 与上一季度对比) | 1351 (-46 与上一季度对比) | +150.9M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $10321765196 | 113750994 | 13.32% | 股份 |
| STATE STREET CORP | $7343246473 | 80926234 | 9.47% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4447881161 | 49017866 | 5.74% | 股份 |
| Capital Research Global Investors | $3349205208 | 36908990 | 4.32% | 股份 |
| Capital International Investors | $3146147651 | 34654113 | 4.06% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $3021806516 | 33484908 | 3.90% | 股份 |
| NORGES BANK | $2119224624 | 23354911 | 2.73% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $988809932 | 10897178 | 1.28% | 股份 |
| FLOSSBACH VON STORCH SE | $902938133 | 9950828 | 1.16% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $887350453 | 9779044 | 1.14% | 股份 |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $873572128 | 9627200 | 1.13% | 股份 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $797974712 | 8794077 | 1.03% | 股份 |
| JANUS HENDERSON GROUP PLC | $780800730 | 7604955 | 1.01% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $737381823 | 8126315 | 0.95% | 股份 |
| CITADEL ADVISORS LLC | $732793646 | 8075751 | 0.95% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $724904438 | 7988808 | 0.94% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $694247236 | 7650948 | 0.90% | 股份 |
| GOLDMAN SACHS GROUP INC | $579394142 | 6385212 | 0.75% | 股份 |
| BlackRock, Inc. | $551881406 | 6082008 | 0.71% | 股份 |
| AMERIPRISE FINANCIAL INC | $547727798 | 6035539 | 0.71% | 股份 |
| BANK OF AMERICA CORP /DE/ | $535831639 | 5905132 | 0.69% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $487309824 | 5370397 | 0.63% | 股份 |
| FMR LLC | $477936254 | 5267096 | 0.62% | 股份 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $447962873 | 4936774 | 0.58% | 股份 |
| Swiss National Bank | $445749361 | 4912380 | 0.58% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $390471098 | 4303186 | 0.50% | 股份 |
| National Pension Service | $381876296 | 4208467 | 0.49% | 股份 |
| ENVESTNET ASSET MANAGEMENT INC | $359002790 | 3956395 | 0.46% | 股份 |
| Legal & General Group Plc | $356621537 | 3930147 | 0.46% | 股份 |
| Vanguard Global Advisers, LLC | $356401041 | 3927717 | 0.46% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $356221103 | 3925734 | 0.46% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $355855239 | 3921702 | 0.46% | 股份 |
| VANGUARD GROUP INC | $352398046 | 2812659 | 0.45% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $326663456 | 3599994 | 0.42% | 股份 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $324048420 | 3571175 | 0.42% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $307912464 | 2999050 | 0.40% | 股份 |
| UBS Group AG | $302485873 | 3333545 | 0.39% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $295969379 | 3261730 | 0.38% | 股份 |
| Assenagon Asset Management S.A. | $292053223 | 3218572 | 0.38% | 股份 |
| JARISLOWSKY, FRASER Ltd | $289054440 | 2158089 | 0.37% | 股份 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $283562500 | 3125000 | 0.37% | 股份 |
| Rathbones Group PLC | $279003540 | 3074758 | 0.36% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $274648102 | 2675057 | 0.35% | 股份 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $262660558 | 2558299 | 0.34% | 股份 |
| STOREBRAND ASSET MANAGEMENT AS | $259462863 | 2859410 | 0.33% | 股份 |
| PNC Financial Services Group, Inc. | $257810942 | 2841205 | 0.33% | 股份 |
| RHUMBLINE ADVISERS | $255936973 | 2820543 | 0.33% | 股份 |
| UBS Group AG | $250750916 | 2763400 | 0.32% | 卖出期权 |
| RAYMOND JAMES FINANCIAL INC | $245980061 | 2710823 | 0.32% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $239769108 | 2642375 | 0.31% | 股份 |
| 1832 Asset Management L.P. | $237351068 | 2615727 | 0.31% | 股份 |
| CITADEL ADVISORS LLC | $234272532 | 2581800 | 0.30% | 买入期权 |
| CANADA PENSION PLAN INVESTMENT BOARD | $230891469 | 2544539 | 0.30% | 股份 |
| Holocene Advisors, LP | $226003396 | 2490670 | 0.29% | 股份 |
| Ninety One UK Ltd | $225389076 | 2483900 | 0.29% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $223999839 | 2467027 | 0.29% | 股份 |
| Ensign Peak Advisors, Inc | $216085151 | 2381366 | 0.28% | 股份 |
| JANE STREET GROUP, LLC | $213973994 | 2358100 | 0.28% | 买入期权 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $211616115 | 2332115 | 0.27% | 股份 |
| LPL Financial LLC | $205718613 | 2267122 | 0.27% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $201807847 | 2224023 | 0.26% | 股份 |
| BARCLAYS PLC | $200112461 | 2205339 | 0.26% | 股份 |
| Qube Research & Technologies Ltd | $194357367 | 2141915 | 0.25% | 股份 |
| California Public Employees Retirement System | $194024624 | 2138248 | 0.25% | 股份 |
| Nuveen Asset Management, LLC | $192921092 | 1705606 | 0.25% | 股份 |
| PeakShares LLC | $184202000 | 2030 | 0.24% | 股份 |
| Fayez Sarofim & Co | $183924904 | 2026944 | 0.24% | 股份 |
| ProShare Advisors LLC | $182849174 | 2015089 | 0.24% | 股份 |
| Mirae Asset Global Investments Co., Ltd. | $171498419 | 1889998 | 0.22% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $171110051 | 1885718 | 0.22% | 股份 |
| US BANCORP \DE\ | $169625636 | 1869359 | 0.22% | 股份 |
| DAVENPORT & Co LLC | $166731901 | 1827013 | 0.22% | 股份 |
| Nuveen, LLC | $165441322 | 1823246 | 0.21% | 股份 |
| Focus Partners Wealth | $159171295 | 1753727 | 0.21% | 股份 |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $156227543 | 1721705 | 0.20% | 股份 |
| FIFTH THIRD BANCORP | $155739304 | 1716325 | 0.20% | 股份 |
| Alecta Tjanstepension Omsesidigt | $145922256 | 1609200 | 0.19% | 股份 |
| Hudson Bay Capital Management LP | $145184000 | 1600000 | 0.19% | 股份 |
| Mizuho Markets Cayman LP | $144086409 | 1587904 | 0.19% | 股份 |
| HighTower Advisors, LLC | $143884700 | 1585681 | 0.19% | 股份 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | $141332725 | 1557555 | 0.18% | 股份 |
| Point72 Asset Management, L.P. | $140822037 | 1551929 | 0.18% | 股份 |
| MACKENZIE FINANCIAL CORP | $140782112 | 1551489 | 0.18% | 股份 |
| GOLDMAN SACHS GROUP INC | $139367566 | 1535900 | 0.18% | 买入期权 |
| AVIVA PLC | $138734382 | 1528922 | 0.18% | 股份 |
| Hudson Bay Capital Management LP | $136110000 | 1500000 | 0.18% | 卖出期权 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $134754435 | 1485061 | 0.17% | 股份 |
| EVERETT HARRIS & CO /CA/ | $131785524 | 1452342 | 0.17% | 股份 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $130414419 | 1432081 | 0.17% | 股份 |
| TD Asset Management Inc | $129183362 | 1423665 | 0.17% | 股份 |
| Vestal Point Capital, LP | $127036000 | 1400000 | 0.16% | 股份 |
| Bank Julius Baer & Co. Ltd, Zurich | $126054316 | 1387458 | 0.16% | 股份 |
| Freestone Grove Partners LP | $124572046 | 1372846 | 0.16% | 股份 |
| Public Sector Pension Investment Board | $124551992 | 1372625 | 0.16% | 股份 |
| Eurizon Capital SGR S.p.A. | $121802182 | 1335277 | 0.16% | 股份 |
| M&G PLC | $120614949 | 1325439 | 0.16% | 股份 |
| ING GROEP NV | $119814457 | 1320415 | 0.15% | 股份 |
| MARSHALL WACE, LLP | $119044891 | 1311934 | 0.15% | 股份 |
| Baird Financial Group, Inc. | $116820060 | 1287415 | 0.15% | 股份 |
| PRUDENTIAL FINANCIAL INC | $115655480 | 1274581 | 0.15% | 股份 |
公司内部人士 103 位内幕人士 · 69 位高管 · 30 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Robert B Ford | President and CEO | 2020年5月15日 G | 135243 | 0 | 0 | $0 |
| Robert E Funck | Executive Vice President & CFO | 2020年10月26日 M | 182217 | 0 | 0 | $0 |
| Brian B Yoor | Executive Vice President & CFO | 2020年2月28日 F | 114099 | 0 | 0 | $0 |
| Jeffrey M Leiden | President and COO | 2006年3月24日 D | 209401 | 0 | 0 | $0 |
| Elizabeth C. Cushman | EVP, GC AND SECRETARY | 2026年6月27日 F | 38013 | 0 | 0 | $0 |
| Gregory A Ahlberg | Senior Vice President | 2020年10月1日 A | 8016 | 0 | 0 | $0 |
| Andrea F Wainer | Executive Vice President | 2020年9月30日 M | 44080 | 0 | 0 | $0 |
| John F Ginascol | Executive Vice President | 2020年9月1日 M | 89003 | 0 | 0 | $0 |
| Roger Bird | Senior Vice President | 2020年9月1日 S | 56630 | 0 | 0 | $0 |
| Daniel Gesua Sive Salvadori | Executive Vice President | 2020年8月27日 M | 102433 | 0 | 0 | $0 |
| John M Capek | Executive Vice President | 2020年8月27日 M | 316800 | 0 | 0 | $0 |
| Mary K Moreland | Executive Vice President | 2020年8月1日 F | 64887 | 0 | 0 | $0 |
| Charles Brynelsen | Senior Vice President | 2020年7月24日 F | 43810 | 0 | 0 | $0 |
| Alejandro D Wellisch | Senior Vice President | 2020年7月21日 F | 21643 | 0 | 0 | $0 |
| Michael J Pederson | Senior Vice President | 2020年7月21日 M | 71454 | 0 | 0 | $0 |
| Lisa D Earnhardt | Executive Vice President | 2020年6月10日 S | 72074 | 0 | 0 | $0 |
| Miles D White | Executive Chairman | 2020年6月4日 G | 3180943 | 0 | 0 | $0 |
| Andrew H Lane | Executive Vice President | 2020年5月5日 M | 65822 | 0 | 0 | $0 |
| Christopher J Scoggins | Senior Vice President | 2020年4月21日 S | 39706 | 0 | 0 | $0 |
| Jaime Contreras | Senior Vice President | 2020年4月21日 M | 62205 | 0 | 0 | $0 |
| Philip P Boudreau | Vice President | 2020年3月13日 S | 22463 | 0 | 0 | $0 |
| Jared Watkin | Senior Vice President | 2020年3月6日 S | 68696 | 0 | 0 | $0 |
| Hubert L Allen | Executive Vice President | 2020年3月2日 S | 151896 | 0 | 0 | $0 |
| DALE MICHAEL D | Senior Vice President | 2020年3月2日 S | 34763 | 0 | 0 | $0 |
| Sammy Karam | Senior Vice President | 2020年2月28日 F | 17921 | 0 | 0 | $0 |
| Joseph J Manning | Senior Vice President | 2020年2月28日 F | 62811 | 0 | 0 | $0 |
| Brian J Blaser | Executive Vice President | 2019年5月23日 M | 130745 | 0 | 0 | $0 |
| Stephen R Fussell | Executive Vice President | 2019年4月23日 M | 169935 | 0 | 0 | $0 |
| Sharon J Bracken | Senior Vice President | 2019年3月31日 D | 5936 | 0 | 0 | $0 |
| Sean Shrimpton | Senior Vice President | 2018年12月31日 F | 16165 | 0 | 0 | $0 |
| Eric S Fain | Senior Vice President | 2017年7月21日 D | 493961 | 0 | 0 | $0 |
| Michael T Rousseau | Pres., Cardiovas. & Neuromod. | 2017年7月7日 F | 183116 | 0 | 0 | $0 |
| Heather L Mason | Executive Vice President | 2017年7月1日 F | 59064 | 0 | 0 | $0 |
| Michael J Warmuth | Executive Vice President | 2017年3月1日 S | 56508 | 0 | 0 | $0 |
| Jean-Yves Pavee | Senior Vice President | 2016年7月1日 F | 36861 | 0 | 0 | $0 |
| Richard W Ashley | Executive Vice President | 2016年2月29日 S | 354517 | 0 | 0 | $0 |
| Thomas G Frinzi | Senior Vice President | 2016年2月19日 A | 31921 | 0 | 0 | $0 |
| Charles D Foltz | Senior Vice President | 2015年4月1日 F | 93333 | 0 | 0 | $0 |
| Scott J. White | Senior Vice President | 2015年3月26日 M | 95719 | 0 | 0 | $0 |
| Georges H. Devos | Senior Vice President | 2015年2月27日 A | 12129 | 0 | 0 | $0 |
| Murthy V Simhambhatla | Senior Vice President | 2015年2月27日 F | 57575 | 0 | 0 | $0 |
| John C Landgraf | Executive Vice President | 2015年2月27日 F | 108972 | 0 | 0 | $0 |
| Katherine C. Doyle | Senior Vice President | 2014年4月15日 S | 43474 | 0 | 0 | $0 |
| David A. Forrest | Senior Vice President | 2013年9月17日 F | 42013 | 0 | 0 | $0 |
| Greg W Linder | Vice President | 2013年2月28日 F | 137475 | 0 | 0 | $0 |
| Magill Paul K | Senior Vice President | 2013年2月15日 A | 33000 | 0 | 0 | $0 |
| Laura J Schumacher | Executive Vice President | 2012年12月11日 M | 179338 | 0 | 0 | $0 |
| James V Mazzo | Senior Vice President | 2012年12月7日 G | 79747 | 0 | 0 | $0 |
| Carlos Alban | Senior Vice President | 2012年11月16日 G | 40442 | 0 | 0 | $0 |
| Robert B Hance | Senior Vice President | 2012年3月1日 S | 144311 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 11 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| [Entities Only] Abbott Laboratories (, Abbott Products, Abbott Investments Luxembourg S.à r.l. ×6 申报 | 2017年3月24日 | — | 初始申报 | — | SEC |
| Abbott Laboratories, Amber Acquisition Inc. ×13 申报 | 2010年4月21日 | — | 初始申报 | 并购/出售 | SEC |
| Abbott Laboratories IRS Identification No. ×11 申报 | 2004年12月16日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2004年1月22日 | — | 初始申报 | 并购/出售 | SEC |
| S. OR | 2002年8月8日 | — | 初始申报 | — | SEC |
| Abbott Laboratories ( | 2002年3月7日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2001年11月1日 | — | 初始申报 | 并购/出售 | SEC |
| 未披露的报告人 | 2001年5月24日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2001年4月17日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2001年3月7日 | — | 初始申报 | — | SEC |
| 未披露的报告人 | 2001年2月16日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 211 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHI · iShares Trust | 18.42% | 5709623 SH | 2026年8月8日 | 每日 |
| PJP · Invesco Exchange-Traded Fund Trust | 5.65% | 264007 SH | 2026年8月8日 | 每日 |
| IYH · iShares Trust | 3.04% | 1037588 SH | 2026年8月8日 | 每日 |
| SCHD · SCHWAB STRATEGIC TRUST | 2.96% | 32820222 NS | 2026年5月31日 | N-PORT |
| HRTS · Tema ETF Trust | 2.61% | 15809 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 2.55% | 801594 NS | 2026年4月30日 | N-PORT |
| IXJ · iShares Trust | 2.38% | 914922 SH | 2026年8月8日 | 每日 |
| HDV · iShares Trust | 2.34% | 3209499 SH | 2026年8月8日 | 每日 |
| VHT · VANGUARD WORLD FUND | 2.33% | 5235711 SH | 2026年8月8日 | 每日 |
| QLTY · GMO ETF Trust | 2.29% | 1204586 NS | 2026年5月31日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 2.28% | 34673 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 2.15% | 18132 NS | 2026年5月31日 | N-PORT |
| QUSA · Tidal Trust III | 2.14% | 4173 NS | 2026年4月30日 | N-PORT |
| FDIV · EA Series Trust | 1.95% | 15623 NS | 2026年4月30日 | N-PORT |
| PRVS · Parnassus Funds II | 1.94% | 5401 NS | 2026年6月30日 | N-PORT |
| OUSA · ALPS ETF Trust | 1.92% | 166396 NS | 2026年5月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.84% | 132886 SH | 2026年8月8日 | 每日 |
| JGRW · Trust for Professional Managers | 1.77% | 19858 NS | 2026年5月31日 | N-PORT |
| PEXL · Pacer Funds Trust | 1.48% | 7452 NS | 2026年4月30日 | N-PORT |
| KNG · First Trust Exchange-Traded Fund IV | 1.42% | 528786 NS | 2026年4月30日 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds ... | 1.41% | 78110 NS | 2026年5月31日 | N-PORT |
| SPXD · DBX ETF Trust | 1.37% | 1082 NS | 2026年5月31日 | N-PORT |
| NOBL · ProShares Trust | 1.35% | 1749432 NS | 2026年5月31日 | N-PORT |
| ANEW · ProShares Trust | 1.32% | 1196 NS | 2026年5月31日 | N-PORT |
| VALQ · AMERICAN CENTURY ETF TRUST | 1.24% | 50554 NS | 2026年5月31日 | N-PORT |
| TMDV · ProShares Trust | 1.23% | 633 NS | 2026年5月31日 | N-PORT |
| EQWL · Invesco Exchange-Traded Fund Trust | 1.15% | 293721 SH | 2026年8月8日 | 每日 |
| DGRO · iShares Trust | 1.11% | 4470372 SH | 2026年8月8日 | 每日 |
| SNPV · DBX ETF Trust | 1.01% | 27271 NS | 2026年5月29日 | N-PORT |
| QIDX · Spinnaker ETF Series | 1.01% | 4283 NS | 2026年4月30日 | N-PORT |
| CGCV · Capital Group Conservative Equity... | 1.00% | 205102 NS | 2026年5月31日 | N-PORT |
| RDVI · First Trust Exchange-Traded Fund IV | 0.90% | 304156 NS | 2026年4月30日 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Inde... | 0.85% | 30132000 | 2026年8月8日 | 每日 |
| CAPE · DoubleLine ETF Trust | 0.84% | 21362 NS | 2026年3月31日 | N-PORT |
| BIGY · Tidal Trust II | 0.82% | 2364 NS | 2026年4月30日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 0.77% | 73722 NS | 2026年4月30日 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 0.75% | 3098502 NS | 2026年5月31日 | N-PORT |
| USMV · iShares Trust | 0.75% | 1691754 SH | 2026年8月8日 | 每日 |
| MGV · VANGUARD WORLD FUND | 0.75% | 1094793 SH | 2026年8月8日 | 每日 |
| FEUS · FlexShares Trust | 0.72% | 8721 NS | 2026年4月30日 | N-PORT |
| DIVB · iShares Trust | 0.71% | 116238 SH | 2026年8月8日 | 每日 |
| CGDG · Capital Group Dividend Growers ETF | 0.71% | 417333 NS | 2026年5月31日 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.70% | 1105961 NS | 2026年4月30日 | N-PORT |
| FYEE · Fidelity Greenwood Street Trust | 0.69% | 12637 NS | 2026年4月30日 | N-PORT |
| CRTC · DBX ETF Trust | 0.69% | 10488 NS | 2026年5月31日 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0.69% | 9840348 SH | 2026年8月8日 | 每日 |
| IWX · iShares Trust | 0.69% | 256287 SH | 2026年8月8日 | 每日 |
| FHEQ · Fidelity Greenwood Street Trust | 0.67% | 61360 NS | 2026年4月30日 | N-PORT |
| PFM · Invesco Exchange-Traded Fund Trust | 0.67% | 49763 SH | 2026年8月8日 | 每日 |
| CGGE · Capital Group Global Equity ETF | 0.66% | 215664 NS | 2026年5月31日 | N-PORT |